New norovirus vaccine approach may help treat other RNA viruses
Base to Base biotech podcast 72: Cell-free DNA bioproduction
KTU chemists develop dual-action compounds to fight cancer
RSV antiviral drug receives FDA approval for phase II trial
University of Aberdeen-led team to trial new drug for heavy menstrual bleeding
Bristol Myers Squibb announces $2.3bn campus in Texas
Mironid raises $46m to advance clinical development of rare kidney disease treatment
Foundation for Angelman Syndrome Therapeutics announces agreement with Apertura Gene Therapy for access to blood-brain barrier-crossing capsid
3D genome mapping in rare immune cells reveals new Crohn’s genes
Cancer cells hijack a fatty acid to escape immune attack in liver metastases
Collaboration aims to develop new class of medicines for in vivo CAR-T
Data validates new method for single-cell transcriptomic tumour profiling from clinical pathology samples